Targeting head and neck tumoral stem cells: From biological aspects to therapeutic perspectives

Abstract

Head and neck squamous cell cancer (HNSCC) is the sixth most common cancer in the world. Effective therapeutic modalities such as surgery, radiation, chemotherapy and combinations of each are used in the management of the disease. In most cases, treatment fails to obtain total cancer cure. In recent years, it appears that one of the key determinants of treatment failure may be the presence of cancer stem cells (CSCs) that escape currently available therapies. CSCs form a small portion of the total tumor burden but may play a disproportionately important role in determining outcomes. CSCs have stem features such as self-renewal, high migration capacity, drug resistance, high proliferation abilities. A large body of evidence points to the fact that CSCs are particularly resistant to radiotherapy and chemotherapy. In HNSCC, CSCs have been increasingly shown to have an integral role in tumor initiation, disease progression, metastasis and treatment resistance. In the light of such observations, the present review summarizes biological characteristics of CSCs in HNSCC, outlines targeted strategies for the successful eradication of CSCs in HNSCC including targeting the self-renewal controlling pathways, blocking epithelial mesenchymal transition, niche targeting, immunotherapy approaches and highlights the need to better understand CSCs biology for new treatments modalities.

Keywords: Biology; Chemotherapy; Head and neck neoplasms; Molecular targeted therapy; Neoplastic stem cells; Oral cancer; Radiation therapy.

Figure 1

Therapeutic perspectives through a multistrategic approach. CSCs: Cancer stem cells; EMT: Epithelial mesenchymal transition.

Figure 2

Immunotherapeutic approaches. CSCs: Cancer stem cells; ALDH: Aldehyde dehydrogenase.